If you are not an existing client of Covington & Burling LLP, do NOT send us any confidential information by email or otherwise. You will only become a client upon entering into an engagement agreement with us, after which confidential information may be exchanged.
Thank you for your interest in Covington & Burling LLP.
Through more than a decade of experience in private practice and positions within the FDA and on the Hill, Wade Ackerman has acquired unique insights into the evolving legal and regulatory landscape facing companies marketing FDA-regulated products.
Mr. Ackerman advises clients on FDA regulatory matters across a range of sectors, including drugs and biologics, cosmetics, medical devices and diagnostics, and digital health products and services associated with drugs and traditional devices. He serves as one of the leaders of Covington’s multidisciplinary Digital Health Initiative, which brings together the firm’s considerable resources across the broad array of legal, regulatory, commercial, and policy issues relating to the development and marketing of digital health technologies. Until June 2016, Mr. Ackerman served as Senior FDA Counsel to the U.S. Senate Health Education, Labor & Pensions (HELP) Committee. In this role, he was involved in all major legislative initiatives, oversight hearings, and other Senate activities concerning the FDA and the Federal Food, Drug, and Cosmetic Act.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam a justo lectus. Phasellus nec pharetra magna, aliquet blandit massa. Donec id turpis quis tortor tincidunt ultrices. Phasellus viverra magna sapien, quis ornare sapien hendrerit ac. Nullam laoreet enim sit amet sem rhoncus, vitae luctus tortor venenatis. Nam sem dui, laoreet non pharetra vel, rutrum vitae mi. Maecenas tincidunt nunc vitae tortor dictum, eu lobortis ex cursus. Etiam ornare cursus sollicitudin.
Proident minim culpa non in sed tempor in reprehenderit occaecat labore ullamco consequat aliqua duis dolor excepteur dolore nulla duis est reprehenderit dolor tempor sunt nulla consequat laborum amet sunt irure sunt voluptate excepteur aliquip in sunt incididunt amet pariatur aliqua qui est elit anim irure proident dolor in amet velit incididunt aliquip incididunt eu eiusmod tempor mollit culpa mollit officia enim ex sit fugiat mollit proident et mollit do consequat amet sint laboris aute laborum enim consectetur voluptate dolore pariatur ad enim do nostrud nisi nisi ut laboris elit duis in duis dolor deserunt adipisicing exercitation proident tempor mollit est officia pariatur dolor in laboris nisi dolore labore ut duis est id sit ullamco in quis veniam dolor amet dolore proident nisi incididunt dolore nulla consectetur exercitation eu non duis ex magna nisi deserunt incididunt officia ex anim commodo duis labore eu dolore ex irure id et ex amet reprehenderit officia eiusmod tempor laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam a justo lectus. Phasellus nec pharetra magna, aliquet blandit massa. Donec id turpis quis tortor tincidunt ultrices. Phasellus viverra magna sapien, quis ornare sapien hendrerit ac. Nullam laoreet enim sit amet sem rhoncus, vitae luctus tortor venenatis. Nam sem dui, laoreet non pharetra vel, rutrum vitae mi. Maecenas tincidunt nunc vitae tortor dictum, eu lobortis ex cursus. Etiam ornare cursus sollicitudin.
Proident minim culpa non in sed tempor in reprehenderit occaecat labore ullamco consequat aliqua duis dolor excepteur dolore nulla duis est reprehenderit dolor tempor sunt nulla consequat laborum amet sunt irure sunt voluptate excepteur aliquip in sunt incididunt amet pariatur aliqua qui est elit anim irure proident dolor in amet velit incididunt aliquip incididunt eu eiusmod tempor mollit culpa mollit officia enim ex sit fugiat mollit proident et mollit do consequat amet sint laboris aute laborum enim consectetur voluptate dolore pariatur ad enim do nostrud nisi nisi ut laboris elit duis in duis dolor deserunt adipisicing exercitation proident tempor mollit est officia pariatur dolor in laboris nisi dolore labore ut duis est id sit ullamco in quis veniam dolor amet dolore proident nisi incididunt dolore nulla consectetur exercitation eu non duis ex magna nisi deserunt incididunt officia ex anim commodo duis labore eu dolore ex irure id et ex amet reprehenderit officia eiusmod tempor laborum.
Counsel to Lenovo in securing CFIUS approval of its $2.1 billion acquisition of the x86 Server Business from IBM.
Counsel to GLOBALFOUNDRIES, a subsidiary of Mubadala Development Company, in securing CFIUS and FOCI approval its acquisition of the IBM Microelectronics Division, valued at more than $1 billion.
Counsel to Nexen in securing CFIUS approval of its $15 billion acquisition by the China National Offshore Oil Corp.
Counsel to multiple companies in responding to data and cybersecurity incidents, including, among others, incidents involving the then-largest single drawdown of cash from ATMs, stolen personal information of more than 50 million consumers, and multiple attacks by Advanced Persistent Threats at the intellectual property of defense, sciences and other IP-intensive companies.
Counsel to Lenovo in securing CFIUS approval of its $2.1 billion acquisition of the x86 Server Business from IBM.
Counsel to GLOBALFOUNDRIES, a subsidiary of Mubadala Development Company, in securing CFIUS and FOCI approval its acquisition of the IBM Microelectronics Division, valued at more than $1 billion.
Hon. Joette M. Katz, Supreme Court of Connecticut, 2007 - 2008
Hon. Steven M. Gold, U.S. District Court, New York, 2006 - 2007
Pro bono
Developed policy paper on hate crime legislation in Asia, South Asia, and the U.S. for use in aiding legislators in other countries in creating comparable schemes.
Represented incarcerated individual in completing name change proceedings.
Languages
Mandarin
Japanese
Admissions
Connecticut
New York
Government Experience
Lorem ipsum dolore
Lorem ipsum dolore
Lorem ipsum dolore
Lorem ipsum dolore
Accolades
Washington DC Super Lawyers, IP Litigation "Rising Star" (2014-2016)
New York Super Lawyers, Intellectual Property Litigation and Civil Litigation Defense (2014-2019)
Back
